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Fig 3. Carotid mycotic aneurysm specimen and histology
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ed for patients who underwent EVAR from 2004 to 2012 and had$1 post-
operative imaging study. DUS was the primary imaging modality after
uncomplicated EVAR, with CTA reserved for patients with suspicious ﬁnd-
ings such as new endoleak or increase in sac size. Correlation between DUS
results and CTA were assessed for sac size and presence and type of
endoleak.
Results: Mean follow-up was 2.2 years for 114 patients. Twenty-
three endoleaks (5 type I, 17 type II, and 1 type IV) were detected in
22 patients. Ten (43%) endoleaks were identiﬁed on DUS alone and
because the aneurysm sac was stable or smaller, CTA was not obtained.
None of these patients suffered subsequent undetected endoleak or
rupture. Eight (35%) endoleaks were identiﬁed initially on DUS and
conﬁrmed by CTA, and three of these patients had secondary interven-
tions. One (4%) endoleak was identiﬁed on CT only. There was one false
positive and three false negative endoleaks on DUS. One patient with
a false negative result had an endoleak identiﬁed on subsequent CTA
and underwent coil embolization. The other two patients’ follow-up
course deviated from our protocol due to severe comorbidities including
renal disease, and therefore, follow-up CTA was not obtained. One of
these patients presented with rupture and death. Among 26 patients
with both DUS and CTA, positive predictive value and negative predictive
value were 0.86 and 0.88, respectively. Sac size on DUS was strongly
correlated to CT (r ¼ 0.8; P < .001).
Conclusions: In our experience, DUS was safe and effective for initial
and follow-up surveillance after uncomplicated EVAR.
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Fig 2. Ruptured carotid mycotic aneurysm resection and reconstructionObjectives: Mycotic aneurysms as a result of intravesical Bacillus
Calmette-Guerin (BCG) treatment are rare. Ruptured carotid mycotic
aneurysms are particularly exceptional and present challenging vascular
surgical problems.
Case Study: A 73-year-old man with a history of lung cancer and
urothelial carcinoma who was undergoing chemotherapy presented to
his primary care physician with a progressivelyenlarging right neck
mass over a 5-month period (Fig 1). He was referred to an otolaryngol-
ogist for a biopsy under local anesthesia. During the attempted biopsy,
the patient developed facial asymmetry and had a near syncopal
episode. Vascular surgery was consulted emergently. A computed
tomography scan was performed, revealing a carotid pseudoaneurysm
within a mass enveloping the carotid bifurcation. The patient under-
went immediate operative exploration. A hard, ﬁbrotic tumor was
encountered just deep to the sternocleidomastoid muscle, emanating
from the carotid sheath (Fig 2). Given the patient’s cancer history,
this was suspected to be a metastatic implant, presenting as a ruptured
aneurysm (Fig 3). We proceeded with radical resection and carotid
replacement using PTFE (Fig 2). His postoperative course was
uneventful, and his facial asymmetry resolved. His ﬁnal pathological
specimen showed necrotizing granulomas and few multinucleated giant
cells concerning for a tuberculoma (Fig 3). Postoperatively, we learned
that the patient’s urothelial carcinoma had been treated with intraves-
ical (BCG). The patient did well postoperatively with anti-tuberculosis
treatment.
Conclusions: Intravesicular BCG immunotherapy is an accepted
treatment for patients with urothelial carcinoma. Rare complications
of arterial mycotic aneurysms have been reported, with the majority
being infrarenal aortic mycotic aneurysms. We describe a rare case of
a carotid mycotic aneurysm following intravesical BCG treatment and
describe its successful management. Symptoms of cervical lymphade-
nopathy in the seeing of BCG treatment should prompt the clinician
to evaluate for systemic tuberculoid dissemination and the possibility
of life-threating mycotic aneurysms. A prosthetic vascular graft can be
a durable repair for a ruptured carotid mycotic aneurysm in the emer-
gent setting.
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Objectives: Primary subclavian vein stents are not recommended due
to risk of fracture as they are compressed between the clavicle and ﬁrst rib.
After thoracic outlet decompression, stent insertion is indicated for venous
re-stenosis. We present a case suggesting that repetitive vein movement
during respiration may induce sufﬁcient strain to cause stent fracture even
after ﬁrst rib removal.
Case Report: A 56-year-old male with a prior venous thoracic outlet
syndrome (TOS) presented with recurrent arm swelling. Six years earlier,
he had undergone a right ﬁrst rib resection for decompression (Fig 1), fol-
lowed a year later with percutaneous transluminal angioplasty (PTA) and
placement of a self- expanding Nitinol stent for right subclavian vein
stenosis (Fig 2). The patient did well for 5 years but then presented to
us with recurrent arm swelling. A venogram revealed a stent fracture and
re-stenosis of the right subclavian vein with minimal contrast ﬂow (Fig
3). Interestingly, we observed that the medial half of the stent was moving
in concert with the movements of the medial part of the subclavian vein.
The fracture of the stent was localized at the junction of the mobile and
Fig 2. Right subclavian vein PTA (a) and stenting (b and c).
Fig 3. Stent fracture and severe subclavian vein stenosis
Fig 4. Stent fracture (blue arrow) at the junction of the immobile and
mobile (black arrows) part of the stent. The red and green lines represent the
centre line of the stent in the lower and the upper position. We note that the
lateral half of the stent is practically not moving while the medial part
demonstrates substantial mobility. The mobility of this fractured stent is
simply an indirect witness for the movements of the subclavian vein. PTA,
Percutaneous transluminal angioplasty
Fig 1. Chest X-ray post ﬁrst rib resection (arrow)
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stent was implanted. During this procedure, two interesting observations
were made: 1) Rotational forces induced a medial and downward motion
with inspiration; and 2) The new intact stent was resistant to these forces
which, however, over time, may be overcome and lead to recurrent
fracture.
Discussion: The increase in interventional treatment for TOS has
been associated with stenting of the subclavian vein following osseous
decompression. In our patient, the repetitive strain on the nitinol stent skel-
eton, created by the moving medial portion of the subclavian vein, may have
signiﬁcantly contributed to stent fracture. Based upon video imaging, it
appears that the lateral part of the subclavian vein moves upward during
inspiration while the proximal medial segment follows the motion of the
mediastinum and moves downwards, leading to an area of repeated ﬂexion
in the midportion of the stent.Endovascular Therapy for Delayed Cryopreserved Bypass Graft
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Objectives: Cryopreserved grafts are increasingly utilized for vascular
reconstruction, particularly in the setting of infection. There are known limi-
tations associated with their use, including graft degeneration with
aneurysm formation. We review our experience with endovascular manage-
ment of delayed complications of cryopreserved bypass grafts.
Methods and Results: Chart review of ﬁve patients who had endo-
vascular repair of cryopreserved bypass graft complications was performed.
Data including indication for surgery, indication for cryopreserved conduit,
complication, time to complication, intervention, and follow-up were ob-
tained. Results are as described in the Table.
Conclusions: Cryopreserved bypass grafts are prone to degeneration
with aneurysm formation. Endovascular therapy provides an initial manage-
ment strategy, however data question their durability as a deﬁnitive
intervention.
